DWTX: Dogwood Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Historical context for DWTX
Across the 3 sessions after earlier DWTX headlines, the stock closed higher 2 times and lower 1 times, with a median move of 6.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | DWTX | SPY |
|---|---|---|---|
| Nov 11, 2025 | Dogwood Announces Enrollment of First 100 Patients in Ongoing Halneuron(R) Phase 2b Trial, Interim Sample Size Analysis on Track for December 2025 | +1.4% | +0.2% |
| Nov 6, 2025 | Dogwood Therapeutics Reports Third Quarter 2025 Financial Results | -6.5% | -1.1% |
| Oct 30, 2025 | Dogwood Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 | +7.8% | -1.1% |
Quantisnow market dataNASDAQ
DWTX
Dogwood Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for DWTX
Full DWTX profile on Quantisnow Follow DWTX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time